BioLife Solutions Inc
NASDAQ:BLFS
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
15.14
27.47
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
BioLife Solutions Inc
Wall Street
Price Targets
BLFS Price Targets Summary
BioLife Solutions Inc
According to Wall Street analysts, the average 1-year price target for
BLFS
is 30.4 USD
with a low forecast of 27.27 USD and a high forecast of 33.6 USD.
BLFS Last Price Targets
BioLife Solutions Inc
The latest public price target was made on Nov 15, 2024 by
Jacob Johnson
from
Stephens
,
who expects
BLFS
stock to
rise by 10%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
|
Jacob Johnson
Stephens
|
30
USD
Upside 10% |
1 month ago
Nov 15, 2024
|
Stephens Reiterates Overweight Rating on BioLife Solutions (BLFS)
StreetInsider
|
|
Matt Hewitt
Craig-Hallum
|
30
USD
Upside 10% |
4 months ago
Aug 12, 2024
|
BioLife Solutions price target raised to $30 from $23 at Craig-Hallum
TheFly
|
Matthew Stanton
Jefferies
|
22
USD
Downside 20% |
8 months ago
Apr 4, 2024
|
Jefferies Starts BioLife Solutions (BLFS) at Buy, 'Getting Back to Basics, Cleaner Story Post Pending Freezer Divestiture'
StreetInsider
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is BLFS's stock price target?
Price Target
30.4
USD
According to Wall Street analysts, the average 1-year price target for
BLFS
is 30.4 USD
with a low forecast of 27.27 USD and a high forecast of 33.6 USD.
What is BioLife Solutions Inc's Revenue forecast?
Projected CAGR
7%
For the last 8 years the
compound annual growth rate for
BioLife Solutions Inc's revenue is
47%.
The projected
CAGR
for the next 4 years is
7%.
You don't have any saved screeners yet
